Related Experiment Video
Updated: Aug 18, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
Three's company: regulation of cell fate by statins
1Rational Drug Design Program, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), 00014 Helsinki, Finland. joannis@scientist.com
Abstract:
Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (statins), the rate-limiting enzyme of the mevalonate biosynthetic pathway, are currently the leading prescription drugs worldwide. Programmed cell death (apoptosis) is a powerful physiological regulator of cellular development, function and dynamics. Statins are known to induce cellular apoptosis in vitro; however, the clinical relevance of this action remains controversial. This paper draws from 15 years' worth of research to explore the impact of statin treatment on cell fate, as represented by the interlinked processes of cellular growth, differentiation and apoptosis. In particular, I outline our current understanding of the pertinent molecular mechanisms; and discuss the evidence for clinical relevance of statin-induced apoptosis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Negative Regulator Molecules
Master Transcription Regulators
Regulation of Expression at Multiple Steps
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Cholesterol: Significance and Regulation
Considering cholesterol and...
